CureLauncher solves the clinical trial enrollment problem. It uses a proprietary process to match people to any enrolling clinical trial.
CureLauncher uses a proprietary, technology-enabled process that connects large support communities, such as LIVESTRONG and Gilda’s Club, to ANY enrolling clinical trial. There are 10,000 new trials in the U.S. annually. Each trial is delayed by 5 months on average due to enrollment issues. CureLauncher's proprietary ACES (Adaptive Clinical Enrollment System) matches people with chronic diseases to trials based on their unique conditions.